Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Transdermal Drug Patches Market 2018, Forecast to 2023

Publisher Name :
Date: 09-Jul-2018
No. of pages: 133

A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.

Scope of the Report:

This report focuses on the Transdermal Drug Patches in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.

Transdermal drug patches mainly has some types, which include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. With medical effect of transdermal drug patches, the downstream application industries will need more transdermal drug patches products.

The major raw materials for transdermal drug patches are scopolamine, clonidine, nitroglycerin, isosorbide dinitrate, estradiol, norethindrone acetate and fentanyl, etc. Fluctuations in the price of the upstream product will impact on the production cost of transdermal drug patches, and then impact the price of transdermal drug patches. The production cost of transdermal drug patches is also an important factor which could impact the price of transdermal drug patches. The transdermal drug patches manufacturers are trying to produce many more types of transdermal drug patches for other different diseases.

The worldwide market for Transdermal Drug Patches is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Noven

- Mylan

- Novartis

- Johnson & Johnson

- Agile Therapeutics

- Teikoku Pharma USA

- Immune Pharmaceuticals

- Hercon Pharmaceuticals

- Pocono

- DURECT Corporation

- Xel Pharmaceuticals

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Fentanyl Transdermal Patch

- Nicotine Transdermal Patch

- Buprenorphine Transdermal Patch

- Clonidine Transdermal Patch

- Oxybutynin Transdermal Patch

- Others

Market Segment by Applications, can be divided into

- Used for Hypertension

- Used for Contraception

- Used for Analgesia

- Used for Smoking Cessation

- Used for Angina

- Used for Hormone Replacement

There are 15 Chapters to deeply display the global Transdermal Drug Patches market.

Chapter 1, to describe Transdermal Drug Patches Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Transdermal Drug Patches, with sales, revenue, and price of Transdermal Drug Patches, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Transdermal Drug Patches, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Transdermal Drug Patches Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Transdermal Drug Patches Introduction
1.2 Market Analysis by Type
1.2.1 Fentanyl Transdermal Patch
1.2.2 Nicotine Transdermal Patch
1.2.3 Buprenorphine Transdermal Patch
1.2.4 Clonidine Transdermal Patch
1.2.5 Oxybutynin Transdermal Patch
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Used for Hypertension
1.3.2 Used for Contraception
1.3.3 Used for Analgesia
1.3.4 Used for Smoking Cessation
1.3.5 Used for Angina
1.3.6 Used for Hormone Replacement
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Noven
2.1.1 Business Overview
2.1.1.1 Noven Description
2.1.1.2 Noven Headquarter, Main Business and Finance Overview
2.1.2 Noven Transdermal Drug Patches Product Introduction
2.1.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.1.2.2 Transdermal Drug Patches Product Information
2.1.3 Noven Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Noven Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Noven Transdermal Drug Patches Market Share in 2017
2.2 Mylan
2.2.1 Business Overview
2.2.1.1 Mylan Description
2.2.1.2 Mylan Headquarter, Main Business and Finance Overview
2.2.2 Mylan Transdermal Drug Patches Product Introduction
2.2.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.2.2.2 Transdermal Drug Patches Product Information
2.2.3 Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Mylan Transdermal Drug Patches Market Share in 2017
2.3 Novartis
2.3.1 Business Overview
2.3.1.1 Novartis Description
2.3.1.2 Novartis Headquarter, Main Business and Finance Overview
2.3.2 Novartis Transdermal Drug Patches Product Introduction
2.3.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.3.2.2 Transdermal Drug Patches Product Information
2.3.3 Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Novartis Transdermal Drug Patches Market Share in 2017
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.1.1 Johnson & Johnson Description
2.4.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.4.2 Johnson & Johnson Transdermal Drug Patches Product Introduction
2.4.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.4.2.2 Transdermal Drug Patches Product Information
2.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Johnson & Johnson Transdermal Drug Patches Market Share in 2017
2.5 Agile Therapeutics
2.5.1 Business Overview
2.5.1.1 Agile Therapeutics Description
2.5.1.2 Agile Therapeutics Headquarter, Main Business and Finance Overview
2.5.2 Agile Therapeutics Transdermal Drug Patches Product Introduction
2.5.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.5.2.2 Transdermal Drug Patches Product Information
2.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Agile Therapeutics Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Agile Therapeutics Transdermal Drug Patches Market Share in 2017
2.6 Teikoku Pharma USA
2.6.1 Business Overview
2.6.1.1 Teikoku Pharma USA Description
2.6.1.2 Teikoku Pharma USA Headquarter, Main Business and Finance Overview
2.6.2 Teikoku Pharma USA Transdermal Drug Patches Product Introduction
2.6.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.6.2.2 Transdermal Drug Patches Product Information
2.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Teikoku Pharma USA Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Teikoku Pharma USA Transdermal Drug Patches Market Share in 2017
2.7 Immune Pharmaceuticals
2.7.1 Business Overview
2.7.1.1 Immune Pharmaceuticals Description
2.7.1.2 Immune Pharmaceuticals Headquarter, Main Business and Finance Overview
2.7.2 Immune Pharmaceuticals Transdermal Drug Patches Product Introduction
2.7.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.7.2.2 Transdermal Drug Patches Product Information
2.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Immune Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Immune Pharmaceuticals Transdermal Drug Patches Market Share in 2017
2.8 Hercon Pharmaceuticals
2.8.1 Business Overview
2.8.1.1 Hercon Pharmaceuticals Description
2.8.1.2 Hercon Pharmaceuticals Headquarter, Main Business and Finance Overview
2.8.2 Hercon Pharmaceuticals Transdermal Drug Patches Product Introduction
2.8.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.8.2.2 Transdermal Drug Patches Product Information
2.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Hercon Pharmaceuticals Transdermal Drug Patches Market Share in 2017
2.9 Pocono
2.9.1 Business Overview
2.9.1.1 Pocono Description
2.9.1.2 Pocono Headquarter, Main Business and Finance Overview
2.9.2 Pocono Transdermal Drug Patches Product Introduction
2.9.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.9.2.2 Transdermal Drug Patches Product Information
2.9.3 Pocono Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Pocono Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Pocono Transdermal Drug Patches Market Share in 2017
2.10 DURECT Corporation
2.10.1 Business Overview
2.10.1.1 DURECT Corporation Description
2.10.1.2 DURECT Corporation Headquarter, Main Business and Finance Overview
2.10.2 DURECT Corporation Transdermal Drug Patches Product Introduction
2.10.2.1 Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
2.10.2.2 Transdermal Drug Patches Product Information
2.10.3 DURECT Corporation Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 DURECT Corporation Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global DURECT Corporation Transdermal Drug Patches Market Share in 2017
2.11 Xel Pharmaceuticals
2.11.1 Business Overview
2.11.2 Xel Pharmaceuticals Transdermal Drug Patches Product Introduction
2.11.3 Xel Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Transdermal Drug Patches Market Competition, by Manufacturer
3.1 Global Transdermal Drug Patches Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Transdermal Drug Patches Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Transdermal Drug Patches Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2017
3.4.2 Top 5 Transdermal Drug Patches Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Transdermal Drug Patches Market Analysis by Regions
4.1 Global Transdermal Drug Patches Sales, Revenue and Market Share by Regions
4.1.1 Global Transdermal Drug Patches Sales by Regions (2013-2018)
4.1.2 Global Transdermal Drug Patches Revenue by Regions (2013-2018)
4.2 North America Transdermal Drug Patches Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Transdermal Drug Patches Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Transdermal Drug Patches Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Transdermal Drug Patches Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Transdermal Drug Patches Sales, Revenue and Growth Rate (2013-2018)
5 North America Transdermal Drug Patches by Countries, Type, Application and Manufacturers
5.1 North America Transdermal Drug Patches Sales, Revenue and Market Share by Countries
5.1.1 North America Transdermal Drug Patches Sales by Countries (2013-2018)
5.1.2 North America Transdermal Drug Patches Revenue by Countries (2013-2018)
5.1.3 United States Transdermal Drug Patches Sales and Growth Rate (2013-2018)
5.1.4 Canada Transdermal Drug Patches Sales and Growth Rate (2013-2018)
5.1.5 Mexico Transdermal Drug Patches Sales and Growth Rate (2013-2018)
5.2 North America Transdermal Drug Patches Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Transdermal Drug Patches Sales by Manufacturers (2016-2017)
5.2.2 North America Transdermal Drug Patches Revenue by Manufacturers (2016-2017)
5.3 North America Transdermal Drug Patches Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Transdermal Drug Patches Sales and Sales Share by Type (2013-2018)
5.3.2 North America Transdermal Drug Patches Revenue and Revenue Share by Type (2013-2018)
5.4 North America Transdermal Drug Patches Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Transdermal Drug Patches Sales and Sales Share by Application (2013-2018)
5.4.2 North America Transdermal Drug Patches Revenue and Revenue Share by Application (2013-2018)
6 Europe Transdermal Drug Patches by Countries, Type, Application and Manufacturers
6.1 Europe Transdermal Drug Patches Sales, Revenue and Market Share by Countries
6.1.1 Europe Transdermal Drug Patches Sales by Countries (2013-2018)
6.1.2 Europe Transdermal Drug Patches Revenue by Countries (2013-2018)
6.1.3 Germany Transdermal Drug Patches Sales and Growth Rate (2013-2018)
6.1.4 UK Transdermal Drug Patches Sales and Growth Rate (2013-2018)
6.1.5 France Transdermal Drug Patches Sales and Growth Rate (2013-2018)
6.1.6 Russia Transdermal Drug Patches Sales and Growth Rate (2013-2018)
6.1.7 Italy Transdermal Drug Patches Sales and Growth Rate (2013-2018)
6.2 Europe Transdermal Drug Patches Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Transdermal Drug Patches Sales by Manufacturers (2016-2017)
6.2.2 Europe Transdermal Drug Patches Revenue by Manufacturers (2016-2017)
6.3 Europe Transdermal Drug Patches Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Transdermal Drug Patches Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Transdermal Drug Patches Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Transdermal Drug Patches Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Transdermal Drug Patches Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Transdermal Drug Patches Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Transdermal Drug Patches by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Transdermal Drug Patches Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Transdermal Drug Patches Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Transdermal Drug Patches Revenue by Countries (2013-2018)
7.1.3 China Transdermal Drug Patches Sales and Growth Rate (2013-2018)
7.1.4 Japan Transdermal Drug Patches Sales and Growth Rate (2013-2018)
7.1.5 Korea Transdermal Drug Patches Sales and Growth Rate (2013-2018)
7.1.6 India Transdermal Drug Patches Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Transdermal Drug Patches Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Transdermal Drug Patches Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Transdermal Drug Patches Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Transdermal Drug Patches Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Transdermal Drug Patches Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Transdermal Drug Patches Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Transdermal Drug Patches Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Transdermal Drug Patches Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Transdermal Drug Patches Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Transdermal Drug Patches Revenue and Revenue Share by Application (2013-2018)
8 South America Transdermal Drug Patches by Countries, Type, Application and Manufacturers
8.1 South America Transdermal Drug Patches Sales, Revenue and Market Share by Countries
8.1.1 South America Transdermal Drug Patches Sales by Countries (2013-2018)
8.1.2 South America Transdermal Drug Patches Revenue by Countries (2013-2018)
8.1.3 Brazil Transdermal Drug Patches Sales and Growth Rate (2013-2018)
8.1.4 Argentina Transdermal Drug Patches Sales and Growth Rate (2013-2018)
8.1.5 Colombia Transdermal Drug Patches Sales and Growth Rate (2013-2018)
8.2 South America Transdermal Drug Patches Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Transdermal Drug Patches Sales by Manufacturers (2016-2017)
8.2.2 South America Transdermal Drug Patches Revenue by Manufacturers (2016-2017)
8.3 South America Transdermal Drug Patches Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Transdermal Drug Patches Sales and Sales Share by Type (2013-2018)
8.3.2 South America Transdermal Drug Patches Revenue and Revenue Share by Type (2013-2018)
8.4 South America Transdermal Drug Patches Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Transdermal Drug Patches Sales and Sales Share by Application (2013-2018)
8.4.2 South America Transdermal Drug Patches Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Transdermal Drug Patches by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Transdermal Drug Patches Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Transdermal Drug Patches Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Transdermal Drug Patches Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Transdermal Drug Patches Sales and Growth Rate (2013-2018)
9.1.4 UAE Transdermal Drug Patches Sales and Growth Rate (2013-2018)
9.1.5 Egypt Transdermal Drug Patches Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Transdermal Drug Patches Sales and Growth Rate (2013-2018)
9.1.7 South Africa Transdermal Drug Patches Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Transdermal Drug Patches Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Transdermal Drug Patches Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Transdermal Drug Patches Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Transdermal Drug Patches Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Transdermal Drug Patches Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Transdermal Drug Patches Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Transdermal Drug Patches Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Transdermal Drug Patches Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Transdermal Drug Patches Revenue and Revenue Share by Application (2013-2018)
10 Global Transdermal Drug Patches Market Segment by Type
10.1 Global Transdermal Drug Patches Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Transdermal Drug Patches Sales and Market Share by Type (2013-2018)
10.1.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2013-2018)
10.2 Fentanyl Transdermal Patch Sales Growth and Price
10.2.1 Global Fentanyl Transdermal Patch Sales Growth (2013-2018)
10.2.2 Global Fentanyl Transdermal Patch Price (2013-2018)
10.3 Nicotine Transdermal Patch Sales Growth and Price
10.3.1 Global Nicotine Transdermal Patch Sales Growth (2013-2018)
10.3.2 Global Nicotine Transdermal Patch Price (2013-2018)
10.4 Buprenorphine Transdermal Patch Sales Growth and Price
10.4.1 Global Buprenorphine Transdermal Patch Sales Growth (2013-2018)
10.4.2 Global Buprenorphine Transdermal Patch Price (2013-2018)
10.5 Clonidine Transdermal Patch Sales Growth and Price
10.5.1 Global Clonidine Transdermal Patch Sales Growth (2013-2018)
10.5.2 Global Clonidine Transdermal Patch Price (2013-2018)
10.6 Oxybutynin Transdermal Patch Sales Growth and Price
10.6.1 Global Oxybutynin Transdermal Patch Sales Growth (2013-2018)
10.6.2 Global Oxybutynin Transdermal Patch Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Transdermal Drug Patches Market Segment by Application
11.1 Global Transdermal Drug Patches Sales Market Share by Application (2013-2018)
11.2 Used for Hypertension Sales Growth (2013-2018)
11.3 Used for Contraception Sales Growth (2013-2018)
11.4 Used for Analgesia Sales Growth (2013-2018)
11.5 Used for Smoking Cessation Sales Growth (2013-2018)
11.6 Used for Angina Sales Growth (2013-2018)
11.7 Used for Hormone Replacement Sales Growth (2013-2018)
12 Transdermal Drug Patches Market Forecast (2018-2023)
12.1 Global Transdermal Drug Patches Sales, Revenue and Growth Rate (2018-2023)
12.2 Transdermal Drug Patches Market Forecast by Regions (2018-2023)
12.2.1 North America Transdermal Drug Patches Market Forecast (2018-2023)
12.2.2 Europe Transdermal Drug Patches Market Forecast (2018-2023)
12.2.3 Asia-Pacific Transdermal Drug Patches Market Forecast (2018-2023)
12.2.4 South America Transdermal Drug Patches Market Forecast (2018-2023)
12.2.5 Middle East and Africa Transdermal Drug Patches Market Forecast (2018-2023)
12.3 Transdermal Drug Patches Market Forecast by Type (2018-2023)
12.3.1 Global Transdermal Drug Patches Sales Forecast by Type (2018-2023)
12.3.2 Global Transdermal Drug Patches Market Share Forecast by Type (2018-2023)
12.4 Transdermal Drug Patches Market Forecast by Application (2018-2023)
12.4.1 Global Transdermal Drug Patches Sales Forecast by Application (2018-2023)
12.4.2 Global Transdermal Drug Patches Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Transdermal Drug Patches Picture
Table Product Specifications of Transdermal Drug Patches
Figure Global Transdermal Drug Patches CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Transdermal Drug Patches CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Transdermal Drug Patches by Types in 2017
Figure Fentanyl Transdermal Patch Picture
Table Major Manufacturers of Fentanyl Transdermal Patch
Figure Nicotine Transdermal Patch Picture
Table Major Manufacturers of Nicotine Transdermal Patch
Figure Buprenorphine Transdermal Patch Picture
Table Major Manufacturers of Buprenorphine Transdermal Patch
Figure Clonidine Transdermal Patch Picture
Table Major Manufacturers of Clonidine Transdermal Patch
Figure Oxybutynin Transdermal Patch Picture
Table Major Manufacturers of Oxybutynin Transdermal Patch
Figure Others Picture
Table Major Manufacturers of Others
Figure Transdermal Drug Patches Sales Market Share by Applications in 2017
Figure Used for Hypertension Picture
Figure Used for Contraception Picture
Figure Used for Analgesia Picture
Figure Used for Smoking Cessation Picture
Figure Used for Angina Picture
Figure Used for Hormone Replacement Picture
Figure United States Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure France Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure UK Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure China Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure India Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Transdermal Drug Patches Revenue (Value) and Growth Rate (2013-2023)
Table Noven Headquarter, Established, Main Business and Finance Overview (2017)
Table Noven Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Noven Transdermal Drug Patches Product
Table Noven Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Noven Transdermal Drug Patches Sales Market Share in 2017
Figure Global Noven Transdermal Drug Patches Revenue Market Share in 2017
Table Mylan Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Mylan Transdermal Drug Patches Product
Table Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan Transdermal Drug Patches Sales Market Share in 2017
Figure Global Mylan Transdermal Drug Patches Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Novartis Transdermal Drug Patches Product
Table Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Transdermal Drug Patches Sales Market Share in 2017
Figure Global Novartis Transdermal Drug Patches Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Transdermal Drug Patches Product
Table Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Transdermal Drug Patches Sales Market Share in 2017
Figure Global Johnson & Johnson Transdermal Drug Patches Revenue Market Share in 2017
Table Agile Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Agile Therapeutics Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Agile Therapeutics Transdermal Drug Patches Product
Table Agile Therapeutics Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Agile Therapeutics Transdermal Drug Patches Sales Market Share in 2017
Figure Global Agile Therapeutics Transdermal Drug Patches Revenue Market Share in 2017
Table Teikoku Pharma USA Headquarter, Established, Main Business and Finance Overview (2017)
Table Teikoku Pharma USA Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Teikoku Pharma USA Transdermal Drug Patches Product
Table Teikoku Pharma USA Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teikoku Pharma USA Transdermal Drug Patches Sales Market Share in 2017
Figure Global Teikoku Pharma USA Transdermal Drug Patches Revenue Market Share in 2017
Table Immune Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Immune Pharmaceuticals Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Immune Pharmaceuticals Transdermal Drug Patches Product
Table Immune Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Immune Pharmaceuticals Transdermal Drug Patches Sales Market Share in 2017
Figure Global Immune Pharmaceuticals Transdermal Drug Patches Revenue Market Share in 2017
Table Hercon Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Hercon Pharmaceuticals Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Hercon Pharmaceuticals Transdermal Drug Patches Product
Table Hercon Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hercon Pharmaceuticals Transdermal Drug Patches Sales Market Share in 2017
Figure Global Hercon Pharmaceuticals Transdermal Drug Patches Revenue Market Share in 2017
Table Pocono Headquarter, Established, Main Business and Finance Overview (2017)
Table Pocono Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table Pocono Transdermal Drug Patches Product
Table Pocono Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pocono Transdermal Drug Patches Sales Market Share in 2017
Figure Global Pocono Transdermal Drug Patches Revenue Market Share in 2017
Table DURECT Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table DURECT Corporation Transdermal Drug Patches Production Bases, Sales Regions and Major Competitors
Table DURECT Corporation Transdermal Drug Patches Product
Table DURECT Corporation Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global DURECT Corporation Transdermal Drug Patches Sales Market Share in 2017
Figure Global DURECT Corporation Transdermal Drug Patches Revenue Market Share in 2017
Table Xel Pharmaceuticals
Table Xel Pharmaceuticals Transdermal Drug Patches
Table Global Transdermal Drug Patches Sales by Manufacturer (2016-2017)
Figure Global Transdermal Drug Patches Sales Market Share by Manufacturer in 2016
Figure Global Transdermal Drug Patches Sales Market Share by Manufacturer in 2017
Table Global Transdermal Drug Patches Revenue by Manufacturer (2016-2017)
Figure Global Transdermal Drug Patches Revenue Market Share by Manufacturer in 2016
Figure Global Transdermal Drug Patches Revenue Market Share by Manufacturer in 2017
Table Global Transdermal Drug Patches Price by Manufacturer (2016-2017)
Figure Top 3 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2017
Figure Global Transdermal Drug Patches Sales and Growth Rate (2013-2018)
Figure Global Transdermal Drug Patches Revenue and Growth Rate (2013-2018)
Table Global Transdermal Drug Patches Sales by Regions (2013-2018)
Table Global Transdermal Drug Patches Sales Market Share by Regions (2013-2018)
Table Global Transdermal Drug Patches Revenue by Regions (2013-2018)
Figure Global Transdermal Drug Patches Revenue Market Share by Regions in 2013
Figure Global Transdermal Drug Patches Revenue Market Share by Regions in 2017
Figure North America Transdermal Drug Patches Sales and Growth Rate (2013-2018)
Figure North America Transdermal Drug Patches Revenue and Growth Rate (2013-2018)
Figure Europe Transdermal Drug Patches Sales and Growth Rate (2013-2018)
Figure Europe Transdermal Drug Patches Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Transdermal Drug
  • Global HPV Therapeutic Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 109
    Human papilloma virus (HPV) vaccines are used to protect against HPV infections. Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs. Scope of the Report: This report focuses on the ......
  • Global Human Chorionic Gonadotropin (HCG) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 117
    Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology. Scope of the Report: This report focuses on the Human Chorionic Gonadotropin (HCG) in global market, especially in North America, Europe and Asi......
  • Global Imatinib Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 120
    Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases. Scope of the Report: This report focuses on the Imatinib Drug in global market, especially in North America, Europe and A......
  • 2018-2023 Global Novel Drug Delivery Systems Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 184
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Novel Drug Delivery Systems market for 2018-2023. Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a......
  • 2018-2023 Global Non-Radioactive Nucleic Acid Labeling Product Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 135
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Non-Radioactive Nucleic Acid Labeling Product market for 2018-2023. In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowe......
  • 2018-2023 Global mRNA Vaccines & Therapeutics Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 136
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global mRNA Vaccines & Therapeutics market for 2018-2023. mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensu......
  • 2018-2023 Global Compounding Pharmacy Market Report (Status and Outlook)
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 130
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Compounding Pharmacy market for 2018-2023. The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to o......
  • Global Japanese Encephalitis ( JE) Vaccine Market Insights, Forecast to 2025
    Published: 18-Sep-2018        Price: US 3900 Onwards        Pages: 110
    This report studies the global market size of Japanese Encephalitis (JE) Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Japanese Encephalitis (JE) Vaccine in these regions. This research report categorizes the global Japanese Encephalitis (JE) Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share,......
  • Global Hematology Treatment Market Insights, Forecast to 2025
    Published: 18-Sep-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Hematology Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hematology Treatment in these regions. This research report categorizes the global Hematology Treatment market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market driver......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs